The need for publishing the silent evidence from negative trials

Acta Psychiatrica Scandinavica

Volumn 123, Issue 2, 2011, Pages 91-94

  Colom, Francesc ^a   Vieta, Eduard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; COGNITIVE THERAPY; EDITORIAL; EVIDENCE BASED MEDICINE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EDITORIAL POLICIES; HUMANS; MENTAL DISORDERS; PERIODICALS AS TOPIC; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78650771529     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2010.01650.x     Document Type: Editorial

References (17)

1. Vieta E, Carné X. The use of placebo in clinical trials on bipolar disorder: a new approach for an old debate. Psychother Psychosom 2005;74:10-16.
2. Ghaemi SN. The case for, and against, evidence-based psychiatry. Acta Psychiatr Scand 2009;119:249-251.
3. Patsopoulos NA, Ioannidis JP, Analatos AA. Origin and funding of the most frequently cited papers in medicine: database analysis. BMJ 2006;332:1061-1064.
4. Yaphe J, Edman R, Knishkowy B, Herman J. The association between funding by commercial interests and study outcome in randomized controlled drug trials. Fam Pract 2001;18:565-568.
5. Procyshyn RM, Chau A, Fortin P, Jenkins W. Prevalence and outcomes of pharmaceutical industry-sponsored clinical trials involving clozapine, risperidone, or olanzapine. Can J Psychiatry 2004;49:601-606.
6. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-1170.
7. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003;289:454-465.
8. Ghaemi SN, Shirzadi A, Filkowski M. Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder. Medscape J Med 2008;10:211.
9. Scott J, Paykel E, Morriss R et al. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry 2006;188:313-320.
10. National Institute for Clinical Excellence. Guideline 38.Bipolar disorder; the management of bipolar disorder in adults, children and adolescents, in primary and secondary care. 2006,.
11. Lam D. What can we conclude from studies on psychotherapy in bipolar disorder? Invited commentary on...Cognitive-behavioural therapy for severe and recurrent bipolar disorders. Br J Psychiatry 2006;188:321-322.
12. Vieta E. Psychiatry: from interest in conflicts to conflicts of interest. World Psychiatry 2007;6:27-29.
13. Callaham M. Journal prestige, publication bias, and other characteristics associated with citation of published studies in peer-reviewed journals. JAMA 2002;287:2847-2850.
14. Jakobsen AK, Christensen R, Persson R, Bartels EM, Kristensen LE. Open access publishing. And now, e-publication bias. BMJ 2010;340:c2243.
15. Vieta E, Cruz N. Increasing rates of placebo response over time in mania studies. J Clin Psychiatry 2008;69:681-682.
16. Patsopoulos NA, Analatos AA, Ioannidis JP. Relative citation impact of various study designs in the health sciences. JAMA 2005;293:2362-2366.
17. Citrome L. Citability of original research and reviews in journals and their sponsored supplements. PLoS ONE 2010;5:e9876.